Business
Novus: Steering Clear of Dilution and Stock Splits
Novus: Steering Clear of Dilution and Stock Splits.
About this update from Novus Acquisition & Development Corp.
[{"type":"text","content":"Novus Acquisition and Development Corp. (OTC Markets: (NDEV) is a leading national supplemental health insurance carrier and pioneer in offering cannabis embedded in health plans for recreational and medicinal users. Presents its perspective on the adverse impacts of dilution and stock splits.Novus, a notable player in the health insurance carrier sector within the cannabis industry, emphasizes the advantages of avoiding dilution and stock splits.With steady EBITDA revenues and Net Asset Value gains, Novus maximizes shareholder value with a robust receivable-based business model that eliminates the need for stock splits, showing our commitment to sustained growth over nearly four years.This strategy lets shareholders benefit from future business expansion while avoiding the downsides of dilution. In contrast, companies resorting to stock splits often signal weakness or adverse challenges.Novus' enduring business model underscores its dedication to navigating the complexities of the cannabis stock landscape. The approval of the Safe Banking Act is expected to trigger a positive shift in the cannabis index. Novus is well-positioned to leverage this growth advantageously.Further Research:Financial Filings: Click HereQuote: Click HereWebsite: Click HereInvestor's Page: Click Here About NovusNovus Acquisition & Development Corp. (NDEV) operates through its subsidiary, WCIG Insurance Services, Inc., offering health insurance and related insurance solutions in states with legal medical marijuana programs. With a robust infrastructure covering various insurance lines, including health, life, and fixed annuities, Novus is a leading health insurance carrier, using two key indicators to gauge value and performance.The Benefit Monetization Ratio measures the annual total of monetized policies, offset by the operating cost ratio, a Balance Sheet line item derived from Net Asset Value and calculated to the Price Book Value.Novus' medical cannabis benefits package operates as an outside developer. It does not engage in any activities related to the cultivation, handling, transportation, growth, extraction, dispensing, sale, marketing, vending, delivery, supply, circulation, or trade of cannabis or any substances violating United States law or the Controlled Substances Act. The company adheres strictly to state and federal laws a...